COMP <GO>
CHRN vs TMO // GROSS PROFIT MARGIN
ChronoScale Holdings Corporation (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: CHRN 0
— TMO 9
■ METRIC PARITY
LAST: $15.62 (-8.26%) • MKT CAP: $2.27B
gross-margins
9.60%
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
gross-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CHRN VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CHRN | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 9.60% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -9.30% | 9.30% | -18.60 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 30.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.53% | 2.40% | -2.93 | TMO | /fcf-yield <GO> |
| Operating Margin | -18.60% | 17.40% | -36.00 | TMO | /operating-margins <GO> |
| Net Profit Margin | -16.30% | 15.10% | -31.40 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | -15.10% | 3.90% | -19.00 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 4.50 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 8/9 | -7.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.1 | 62.9 | -23.83 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 36.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.27B | $262.22B | -$259.94B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CHRN REV | TMO REV | CHRN GROSS % | TMO GROSS % | CHRN FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $71.6M | $44.56B | 9.6% | — | -$12.0M | $6.29B |
| FY 2024 | $84.4M | $42.88B | 11.3% | — | -$9.9M | $7.27B |
| FY 2023 | $0 | $42.86B | — | — | -$12.1M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CHRN // BETA —
TMO // BETA 0.94